Professor Sanjay M Sisodiya
"We want to bring in all that information that the genome contains so that we can better tailor treatment for each individual."
Sanjay Sisodiya is Professor of Neurology at UCL Queen Square Institute of Neurology and Honorary Consultant Neurologist at the National Hospital for Neurology and Neurosurgery and Director of Genomics at Epilepsy Society.
Background
Professor Sisodiya studied medicine at the University of Cambridge and Guy’s Hospital, and trained in Neurology in Oxford and at the National Hospital for Neurology and Neurosurgery. He was awarded a PhD for working in brain magnetic resonance imaging in epilepsy and has made major contributions to epilepsy genetics, epilepsy pharmacogenetics.
He is Professor of Neurology at UCL Queen Square Institute of Neurology, Consultant Neurologist at the UCLH National Hospital for Neurology and Neurosurgery, and Director of Genomics at the Epilepsy Society. He runs specialist epilepsy clinics, including an epilepsy genomics clinic, for the evaluation and management of epilepsy in adults.
He is currently Chair of the Epilepsy Advisory Group of the Association of British Neurologists, Chair of the International League Against Epilepsy Joint Task Force on Clinical Genetic Testing in the Epilepsies, and a member of the Scientific Advisory Board of Dravet Syndrome UK and patron of Alternating Hemiplegia of Childhood UK.
Research Interests
Difficult-to-treat epilepsy, epilepsy genomics and pharmacogenomics, novel phenotyping, translational genomics.
Professor Sisodiya is joint chief investigator of the ENIGMA-Epilepsy Project and Coordinator of the EU-funded epilepsy pharmacogenomics project EpiPGX.
Areas of supervison
Sanjay is the principal investigator for the EpilepsyPlus, SUDEP, Clinical translation, and TMS-EEG projects. He is also the chief investigator of the ENIGMA-Epilepsy Project; and of the EU-funded epilepsy pharmacogenomics project EpiPGX.
Publications
Atypical face shape and genomic structural variants in epilepsy
Genome annotation for clinical genomic diagnostics: strengths and weaknesses
Field loss over 10 years in individuals taking vigabatrin
Long-interval intracortical inhibition as biomarker for epilepsy
All publications: https://iris.ucl.ac.uk/iris/browse/profile?upi=SMSIS90
Our research
Genomics
Read how we are working to understand the genetic architecture of each individual person's epilepsy through our world leading genomics research programme.
Neuroimaging
Neuroimaging enables us to look deep inside the brain to learn more about the impact of seizures on its structure and function.
Neuropathology
The Epilepsy Society Brain and Tissue Bank is the first of its kind in the UK. It is dedicated to the study of epilepsy through brain and other tissue samples.